Ganoderma lucidum KCCM 10045 which produces proteoglycan (G009)

Details Ganoderma lucidum KCCM 10045 which produces proteoglycan (G009) Ganoderma lucidum KCCM 10045 which produces proteoglycan (G009)

1995-10-04

1998-02-24

Naff, David M.

Chemistry: molecular biology and microbiology

Micro-organism, per se ; compositions thereof; proces of...

Fungi

424935, 435911, C12N 100, C12N 114

Patent

active

057211345

ABSTRACT:
This invention relates to a strain, Ganoderma lucidum IY 009 which produces a proteoglycan G 009 possessed of antitumoral and immunostimulating effects, separated from the said cultured strain, containing: .beta.-glucose, .alpha.-glucose, galactose, .alpha.-mannose and fructose as saccharide components, and glycine, alanine, histidine, arginine, valine, aspartic acid, threonine, isoleucine, serine, leucine, glutamic acid, tyrocine, proline, phenylalanine and methionine as protein components. The Ganoderma lucidum IY 009 is deposited under accession number KCCM 10045.

REFERENCES:
patent: 4051314 (1977-09-01), Ohtsuka et al.
patent: 4145415 (1979-03-01), Akihiko
patent: 4472907 (1984-09-01), Wada et al.
patent: 5585467 (1996-12-01), Lee et al.

Affiliated with

Also associated with

Rating

Ganoderma lucidum KCCM 10045 which produces proteoglycan (G009) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ganoderma lucidum KCCM 10045 which produces proteoglycan (G009) , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ganoderma lucidum KCCM 10045 which produces proteoglycan (G009) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1874642